BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27522523)

  • 21. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BAG3 promotes chondrosarcoma progression by upregulating the expression of β-catenin.
    Shi H; Chen W; Dong Y; Lu X; Zhang W; Wang L
    Mol Med Rep; 2018 Apr; 17(4):5754-5763. PubMed ID: 29484408
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberration of
    Liu P; Garbutt C; Hornicek FJ; Liu F; Duan Z
    Anticancer Res; 2017 Jun; 37(6):2939-2945. PubMed ID: 28551631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of elevated HIF-2α levels with low Beclin 1 expression and poor prognosis in patients with chondrosarcoma.
    Chen C; Ma Q; Ma X; Liu Z; Liu X
    Ann Surg Oncol; 2011 Aug; 18(8):2364-72. PubMed ID: 21327823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma.
    Hong Y; Chen W; Du X; Ning H; Chen H; Shi R; Lin S; Xu R; Zhu J; Wu S; Zhou H
    Oncotarget; 2015 Oct; 6(31):31241-54. PubMed ID: 26384302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
    Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
    Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
    Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
    Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer.
    Li D; Zhao X; Xiao Y; Mei H; Pu J; Xiang X; Jiao W; Song H; Qu H; Huang K; Zheng L; Tong Q
    Oncotarget; 2015 Jun; 6(18):16168-82. PubMed ID: 25965823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic silencing of SFRP5 promotes the metastasis and invasion of chondrosarcoma by expression inhibition and Wnt signaling pathway activation.
    Sheng W; Zhang ZC; Shi DY; Wang BC; Wu Q; Shao ZW; Yang SH; He TC; Liu JX
    Chem Biol Interact; 2018 Dec; 296():1-8. PubMed ID: 30125549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bortezomib induces apoptosis and suppresses cell growth and metastasis by inactivation of Stat3 signaling in chondrosarcoma.
    Bao X; Ren T; Huang Y; Ren C; Yang K; Zhang H; Guo W
    Int J Oncol; 2017 Feb; 50(2):477-486. PubMed ID: 28000897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcoma.
    Karras FS; Schreier J; Körber-Ferl K; Ullmann SR; Franke S; Roessner A; Jechorek D
    Pathol Res Pract; 2023 Apr; 244():154414. PubMed ID: 36963273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.
    Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C
    Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.
    Fang T; Cui M; Sun J; Ge C; Zhao F; Zhang L; Tian H; Zhang L; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li H; Li J
    Oncotarget; 2015 Jun; 6(18):16106-19. PubMed ID: 25965830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk.
    Ye Y; Xiao L; Wang SJ; Yue W; Yin QS; Sun MY; Xia W; Shao ZY; Zhang H
    Oncotarget; 2016 Jan; 7(4):3921-33. PubMed ID: 26646797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance.
    Kumari R; Li H; Haudenschild DR; Fierro F; Carlson CS; Overn P; Gupta L; Gupta K; Nolta J; Yik JH; Di Cesare PE
    Carcinogenesis; 2012 Nov; 33(11):2076-83. PubMed ID: 22847180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amphiregulin enhances alpha6beta1 integrin expression and cell motility in human chondrosarcoma cells through Ras/Raf/MEK/ERK/AP-1 pathway.
    Chen JC; Chen YJ; Lin CY; Fong YC; Hsu CJ; Tsai CH; Su JL; Tang CH
    Oncotarget; 2015 May; 6(13):11434-46. PubMed ID: 25825984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
    Li X; Xu R; Liu H; Fang K
    Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.
    Li Y; Jin K; van Pelt GW; van Dam H; Yu X; Mesker WE; Ten Dijke P; Zhou F; Zhang L
    Cancer Res; 2016 Jun; 76(11):3364-75. PubMed ID: 27197202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
    Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
    Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.